DR, G., N, G., S, M., S, H., BA, C., SA, S., . . . EH, K. (2007). Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals. Alzheimer disease and associated disorders, 21(4), 292. https://doi.org/10.1097/WAD.0b013e31815d1048
Chicago Style (17th ed.) CitationDR, Galasko, et al. "Safety, Tolerability, Pharmacokinetics, and Abeta Levels After Short-term Administration of R-flurbiprofen in Healthy Elderly Individuals." Alzheimer Disease and Associated Disorders 21, no. 4 (2007): 292. https://doi.org/10.1097/WAD.0b013e31815d1048.
MLA (9th ed.) CitationDR, Galasko, et al. "Safety, Tolerability, Pharmacokinetics, and Abeta Levels After Short-term Administration of R-flurbiprofen in Healthy Elderly Individuals." Alzheimer Disease and Associated Disorders, vol. 21, no. 4, 2007, p. 292, https://doi.org/10.1097/WAD.0b013e31815d1048.